✦ LIBER ✦

Novel Quinazolinone Derivatives as Possible Antitumor Agents

✍ Scribed by Barakat, Saber El-Sayed; Ghorab, Moustafa M.; Saker, Helmy M.; Abd Rabo, Mahmoud M.

Book ID: 115461837
Publisher: Taylor and Francis Group
Year: 2007
Tongue: English
Weight: 1020 KB
Volume: 182
Category: Article
ISSN: 1042-6507
DOI: 10.1080/10426500600867042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NOVEL QUINAZOLONE DERIVATIVES AS ANTITUM

NOVEL QUINAZOLONE DERIVATIVES AS ANTITUMOR AGENTS

✍ Ghorab, M. M.; Abdel-hamide, S. G.; El-sayed, S. M. 📂 Article 📅 1998 🏛 Taylor and Francis Group 🌐 English ⚖ 486 KB

Synthesis and Evaluation of Some Novel Q

Synthesis and Evaluation of Some Novel Quinazolinone Derivatives as Diuretic Agents.

✍ Azza R. Maarouf; Eman R. El-Bendary; Fatma E. Goda 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 36 KB 👁 2 views

Synthesis and Evaluation of some Novel Q

Synthesis and Evaluation of some Novel Quinazolinone Derivatives as Diuretic Agents

✍ Azza R. Maarouf; Eman R. El-Bendary; Fatma E. Goda 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

Synthesis of benzoxazino-and naphthoxazi

Synthesis of benzoxazino-and naphthoxazinoquinoline derivatives as possible antitumor agents

✍ M. Nasr; M. M. Abbasi; I. Nabih 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

Novel 3-Benzoyl-2-piperazinylquinoxaline

Novel 3-Benzoyl-2-piperazinylquinoxaline Derivatives as Potential Antitumor Agents.

✍ Sandra Piras; Mario Loriga; Antonio Carta; Giuseppe Paglietti; M. Paola Costi; S 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

Novel 3-benzoyl-2-piperazinylquinoxaline

Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents

✍ Sandra Piras; Mario Loriga; Antonio Carta; Giuseppe Paglietti; M. Paola Costi; S 📂 Article 📅 2006 🏛 Journal of Heterocyclic Chemistry 🌐 English ⚖ 202 KB

## Abstract magnified image A series of new benzoylquinoxaline derivatives (**7‐26**) was synthesized and evaluated for antitumor activity against a panel of 60 human cell lines at the NCI of Bethesda. Among the compounds which have passed the preliminary screening, compound **23** exhibited the b